BG104706A - Derivatives of 1,3,4-oxadiazolone - Google Patents

Derivatives of 1,3,4-oxadiazolone

Info

Publication number
BG104706A
BG104706A BG104706A BG10470600A BG104706A BG 104706 A BG104706 A BG 104706A BG 104706 A BG104706 A BG 104706A BG 10470600 A BG10470600 A BG 10470600A BG 104706 A BG104706 A BG 104706A
Authority
BG
Bulgaria
Prior art keywords
oxadiazolone
derivatives
solvate
disorders
responsive
Prior art date
Application number
BG104706A
Other languages
Bulgarian (bg)
English (en)
Inventor
Piyasena Hewawasam
Min Ding
John STARRETT
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of BG104706A publication Critical patent/BG104706A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BG104706A 1998-01-29 2000-08-22 Derivatives of 1,3,4-oxadiazolone BG104706A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (1)

Publication Number Publication Date
BG104706A true BG104706A (en) 2001-04-30

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104706A BG104706A (en) 1998-01-29 2000-08-22 Derivatives of 1,3,4-oxadiazolone

Country Status (27)

Country Link
US (1) US6034113A (no)
EP (1) EP1051173A4 (no)
JP (1) JP2002527352A (no)
KR (1) KR20010077838A (no)
CN (1) CN1150175C (no)
AR (1) AR010712A1 (no)
AU (1) AU735704B2 (no)
BG (1) BG104706A (no)
BR (1) BR9913010A (no)
CA (1) CA2318830A1 (no)
CO (1) CO5090837A1 (no)
EE (1) EE04089B1 (no)
GE (1) GEP20032914B (no)
HU (1) HUP0102025A3 (no)
ID (1) ID26909A (no)
IL (1) IL137518A0 (no)
LT (1) LT4838B (no)
LV (1) LV12559B (no)
NO (1) NO317102B1 (no)
NZ (1) NZ505409A (no)
PL (1) PL342060A1 (no)
RU (1) RU2202548C2 (no)
SK (1) SK10852000A3 (no)
TR (1) TR200002019T2 (no)
TW (1) TW550075B (no)
UA (1) UA58579C2 (no)
WO (1) WO1999038510A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en) * 1999-01-29 2000-12-19 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
CN100540538C (zh) * 2001-04-16 2009-09-16 田边三菱制药株式会社 高传导率钙-活化k通道开启剂
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
ES2969344T3 (es) 2012-01-18 2024-05-17 Techfields Pharma Co Ltd Composiciones de profármaco de alta penetración y composición farmacéutica del mismo para el tratamiento de afecciones pulmonares
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
AU2018225758A1 (en) * 2017-02-24 2019-09-05 Ovid Therapeutics Inc. Methods of treating seizure disorders
US12194026B2 (en) 2018-10-26 2025-01-14 University Of South Florida Drug for treating tinnitus
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (no) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone

Also Published As

Publication number Publication date
LV12559A (en) 2000-11-20
KR20010077838A (ko) 2001-08-20
PL342060A1 (en) 2001-05-21
LV12559B (en) 2001-04-20
EE04089B1 (et) 2003-08-15
TR200002019T2 (tr) 2000-11-21
NO20003825D0 (no) 2000-07-26
TW550075B (en) 2003-09-01
CO5090837A1 (es) 2001-10-30
LT2000068A (en) 2001-03-26
UA58579C2 (uk) 2003-08-15
CN1150175C (zh) 2004-05-19
US6034113A (en) 2000-03-07
GEP20032914B (en) 2003-03-25
EE200000447A (et) 2001-12-17
AU2230899A (en) 1999-08-16
RU2202548C2 (ru) 2003-04-20
SK10852000A3 (sk) 2002-02-05
ID26909A (id) 2001-02-15
HUP0102025A2 (hu) 2001-11-28
JP2002527352A (ja) 2002-08-27
EP1051173A4 (en) 2002-07-31
LT4838B (lt) 2001-08-27
CN1289249A (zh) 2001-03-28
NO317102B1 (no) 2004-08-09
HUP0102025A3 (en) 2002-01-28
IL137518A0 (en) 2001-07-24
CA2318830A1 (en) 1999-08-05
NO20003825L (no) 2000-07-26
BR9913010A (pt) 2001-05-08
NZ505409A (en) 2003-08-29
AU735704B2 (en) 2001-07-12
WO1999038510A1 (en) 1999-08-05
EP1051173A1 (en) 2000-11-15
AR010712A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
MY115935A (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
CA2354023A1 (en) Phenylglycine derivatives
BG105270A (en) Tetrahydropyridoethers
LV12559A (en) Derivatives of 1,3,4-oxadiazolone
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
BG106586A (en) Pyrazolopyramidines as therapeutic agents
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
AU1074702A (en) Sulfamides as gamma-secretase inhibitors
AP2002002637A0 (en) Novel piperazine
AU8692391A (en) Improvements in or relating to organic compounds
MY126559A (en) Fungicidal 2-methoxybenzophenones
AU6563596A (en) Treatment of tinnitis using neuroprotective agents
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
MXPA04001686A (es) Combinaciones de productos activos fungicidas.
CA2474511A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
WO2002016369A3 (en) Novel macrocycles and uses thereof
PT1056754E (pt) Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
USD427384S (en) Hockey glove
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
DE69837999D1 (en) Herbizide furanyl- und thienyloxyazine
CA2302412A1 (en) Aminoalkylphenol derivatives and related compounds
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof